OUTRUN TX
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
OUTRUN TX
Industry:
Health Care Medical Therapeutics
Address:
Dundee, Dundee City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.outruntx.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Investors List
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Seed Round - Outrun TX
Official Site Inspections
http://www.outruntx.com
- Host name: 59.0.153.160.host.secureserver.net
- IP address: 160.153.0.59
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Outrun TX"
Outrun Therapeutics – Unlocking the therapeutic potential of …
Jan 13, 2025 Our Approach Outrun Therapeutics is a preclinical biotech using E3 ligase inhibition to unlock the therapeutic potential of protein stabilisation for the treatment of cancer …See details»
Outrun TX - Crunchbase Company Profile & Funding
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.See details»
Outrun TX - Products, Competitors, Financials, Employees, …
Jan 13, 2025 About Outrun TX Outrun TX focuses on the development of treatments for cancer and other diseases through protein stabilization. The company's main offerings include a …See details»
Outrun TX 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Outrun TX. Use the PitchBook Platform to explore the full profile.See details»
Outruntx - Company Profile - Tracxn
Outruntx - Developer of therapeutics for cancer treatment. Raised a total funding of $10M over 1 round from 2 investors.See details»
Member profile: Outrun Therapeutics | BIA
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 ligase inhibition to maintain levels of critical proteins that are otherwise destabilised in certain …See details»
Outrun Therapeutics - VentureRadar
"Outrun Therapeutics is dedicated to combating diseases such as cancer and neurodegeneration by focusing on the degradation of critical proteins. The company aims to restore health …See details»
Outrun TX | F6S
Outrun TX - Developer of a technology designed for the identification of therapeutics that selectively target the protein degradation pathway. The company provides a proprietary …See details»
Our Company – Outrun Therapeutics
Carolyn has over 25 years’ experience in a career spanning roles in University spin-outs, biotech and biopharmaceutical companies, technology transfer and academia. She has held Board roles in 7 biotech companies including CEO …See details»
About OUTRUN THERAPEUTICS | DxMultiomics
OUTRUN THERAPEUTICS | on DxMultiomics. Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 ligase inhibition to maintain levels of critical proteins that …See details»
Outrun Therapeutics Ltd | Welcome to Bio-Dundee
The team specialise in developing small molecule inhibitors that prevent protein degradation by targeting E3 ligases. Their lead program focuses on a small molecule inhibitor for a hard-to …See details»
Outrun Therapeutics - Founder Lodge
19/04/2024 Seed $10,000,000 Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.See details»
Outruntx - 2025 Funding Rounds & List of Investors - Tracxn
3 days ago Outruntx has raised a total funding of $10M over 1 round from 2 investors. Investors include MP Healthcare Venture Management and M Ventures. Their latest funding round was …See details»
Contact – Outrun Therapeutics
General Enquiries For general enquiries please contact [email protected] Partnering Enquiries If you are interested in our world leading platform please contact [email protected]See details»
Outrun Therapeutics Overview | SignalHire Company Profile
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.See details»
Our Approach – Outrun Therapeutics
Degradation of critical proteins in disease Cancer and neurodegeneration can hijack E3 ligase controlled processes and degrade critical proteins, enabling the disease to develop and spread.See details»
Outrun TX - Profiles & Contacts - Crunchbase
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.See details»
Outrun Therapeutics expands leadership team with appointment …
Jan 13, 2025 For more information, see: https://outruntx.com About Matthew Fyfe Matthew has over 25 years’ experience in drug discovery and development, having formerly held Senior …See details»
Careers – Outrun Therapeutics
Tenacity Breaking new scientific ground is hard, we are tenacious in pursuit of our goals and entrepreneurial in their delivery. If you are interested in joining our team, please get in touch: …See details»
Ken Paxton launches investigation into Beto O’Rourke-led group …
5 hours ago Ken Paxton launches investigation into Beto O’Rourke-led group over Texas quorum break The organization, Powered by People, has reportedly been helping support …See details»